openPR Logo
Press release

Unprecedented Market Exits a Reality Check for Measuring Glucose Noninvasively

06-12-2018 08:23 AM CET | Health & Medicine

Press release from: Greystone Research Associates

(Amherst, NH) – Very few medical device markets can claim to exceed noninvasive glucose monitors (NGM) for marketing hype, product pronouncements and unkept promises. Fueled by patient enthusiasm and investor amnesia, this market has survived a long string of missed deadlines, perpetually postponed milestones and re-designed web sites. Along the way, one by one most participants have become casualties. In the ten years since we first began to track noninvasive glucose measurement technology, only one company remains active in this segment.

While many of the underlying technologies needed to successfully create a new class of analyte monitors have improved significantly – signal-to-noise ratios, novel optical techniques, and sensor stability to name a few - the complexities of measuring glucose levels noninvasively have not been mastered. As a group, the handful of techniques and companies that comprise the current NGM marketspace are less complicated and more restrained. They also tend to have two things that every savvy medical device investor insists on – patents and clinical trial activity.

We expect the current crop of NGM products to yield two, and possibly three, commercial devices over the next six years. Success will be real but gradual, with total revenue in 2024 equivalent to slightly less than one percent of the total global glucose measurement market.

More information is available at www.greystoneassociates.org .

Contact:

Mark Smith
Voice: 603-595-4340
www.greystoneassociates.org

Source: Greystone Research Associates

About Greystone

Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets

Contact:

Mark Smith
Greystone Research Associates
98 Route 101A
Amherst, NH 03031
Voice: 603-595-4340
www.greystoneassociates.org

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Unprecedented Market Exits a Reality Check for Measuring Glucose Noninvasively here

News-ID: 1078023 • Views: 165

More Releases from Greystone Research Associates

Seeking to Capitalize on New Device Technology Drug Companies are Reformulating …
(Amherst, NH) – As the pace of competition increases within the pharmaceutical and biotech industries, the concept of life cycle management is becoming a key component of drug product management. Much of the recent emphasis in this area has centered on efforts to extend patent rights protection. While reformulation has been and is an important approach, efforts to prolong IP benefits have only recently involved IV-to-SC drug re-engineering. This migration
Antibacterial Treatments that don’t Rely on Antibiotics Winding their way thro …
(Amherst, NH) – As bacteria grow resistant to conventional antibiotics, alternatives are being investigated, including antibodies, probiotics, bacteriophages, and antimicrobial peptides. The quest to replace the current generation of antibiotics is complicated by the methods that bacteria have acquired to evade attempts to destroy them – methods often referred to a virulence factors. A microorganism can possess a wide array of virulence factors. They may only express these virulence factors when
3D Printing Positioned to Address Issues that have Prevented Wide Adoption of Mi …
(Amherst, NH) – The promise of commercial microneedle drug delivery has been on the horizon for more than a decade. Like other compelling medical device innovations such as noninvasive glucose monitoring, the potential of the technology has yet to be realized due to the inability to solve the issues of reliable product performance from unit to unit and across a wide user population. To fully address the unmet need these technologies
Analysis of the Oncology Drug Pipeline Reveals Evolving Therapy Correlations and …
(Amherst, NH) – The almost two thousand active oncology clinical trials paint a picture of an evolving therapeutic sector that has established players moving quickly to realize the expanded benefits of recent treatment protocols. A dozen targeted treatments, using novel pathways and signaling, have achieved results that represent a new era in oncology and antineoplastic therapeutics. There approaches have attracted a growing number of drug developers anxious to profit from

All 5 Releases


More Releases for NGM

Primary Sclerosing Cholangitis Market Growth, Demand and Forecast Till 2023 Expl …
Primary sclerosing cholangitis market report provides detailed information about various candidates that are presently in the preclinical and clinical trials by the manufacturers and research organizations. The drug segment will provide quick snapshot about the clinical phase of the study, study outcomes, estimated launch date, and the upcoming drug molecules. Moreover, the report entails information regarding the major events taking place in the global market, thereby gaining insights about drug
Primary Sclerosing Cholangitis Market Booming Worldwide and Benefits is Explore …
Primary sclerosing cholangitis market report provides detailed information about various candidates that are presently in the preclinical and clinical trials by the manufacturers and research organizations. The drug segment will provide quick snapshot about the clinical phase of the study, study outcomes, estimated launch date, and the upcoming drug molecules. Moreover, the report entails information regarding the major events taking place in the global market, thereby gaining insights about drug
Constipation - Pipeline Review, H1 2019 by:Allergan Plc, Ardelyx Inc, Braintree …
Constipation - Pipeline Review, H1 2019 Summary Reports Intellect's latest Pharmaceutical and Healthcare disease pipeline guide Constipation - Pipeline Review, H1 2019, provides an overview of the Constipation (Gastrointestinal) pipeline landscape. Constipation refers to the infrequent or difficult passing of stool. Constipation occurs when bowel movements become difficult or less frequent. Symptoms of constipation include swollen abdomen or abdominal pain, pain and vomiting. The predisposing factors include eating disorders, irritable bowel syndrome, and
The next-generation memory (NGM) market is expected to reach from 2.35 Billion i …
In this report, Research Reports Inc. studies the present scenario (with the base year being 2017) and the growth prospects of global Next Generation Memory Technologies market for 2018-2023. Next Generation Memory Technologies include emerging memory solutions that have been introduced in the market in the recent years. The next-generation memory (NGM) market is expected to reach from 2.35 Billion in 2017 to USD 9.63 Billion by 2023, at a CAGR of
Primary Sclerosing Cholangitis Market Revenue Opportunies By Key Vendors Acorda …
Global Primary Sclerosing Cholangitis Market, by Drug (BT1023, GS-9674, NGM282, OCA, LUM001, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) has potential pipeline products and is estimated to reach US$ 140.4 Mn by 2023, as highlighted in a new report published by Coherent Market Insights. Pharmaceutical companies are focusing on enhancing research and development for introducing novel therapeutics to address unmet patient needs.
Next-Generation Memory (NGM) Market 2018 Global Key Leaders: IBM Corporation, To …
Market Scenario: The next generation memory market has grown over the last few years because of the increasing demand for faster, efficient and cost effective memory solutions. These new generation memory solutions are used across various verticals. Nowadays, smart chips are used for storage instead of hard drives. According to market research future, the market segmentation of next-generation memory market can be into product, application and region. The new memory storage solutions